Top 10 Biotechnology Angel Investors in Oceania in July 2025
A list of 10 angel investors that invest in Biotechnology startups based in Oceania. We rank investors based on the number of investments they made in Biotechnology companies from Oceania. We update this investor list every month.Top 10 Biotechnology Angel Investors in Oceania in July 2025
Investor | Biotechnology Oceania investments |
---|---|
Mike Wallas | 2 |
Allan Moss | 2 |
Paul Davidson | 1 |
Latesha Randall | 1 |
Serge van Dam | 1 |
Daniel Petre | 1 |
Melanie Melanie | 1 |
Marko Bogoievski | 1 |
Catherine Lacavera | 1 |
David Ross | 1 |
Mike Wallas - Advisory Board @ Optifire Pty Ltd
Show more
Investment focus
- Video, Water, Biotechnology
- Seed, Funding Round
- Australia
Portfolio highlights
- PERKii — PERKii Targeted Release Probiotics are naturally micro-shielded to resist stomach acid up to 10,000x stronger than non micro-shield probiotics. For a targeted release in your gut and a difference you can feel. PERKii Probiotic Drinks are bottled with one billion or more probiotics per serve.
- Clipchamp — Free video editing tool everyone can use. Get started in your browser, download the Windows app or create on the go with your mobile. Clipchamp's smart tools and royalty-free content help you create in minutes. Export in 4K and share in an instant.
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Funding Round, Series A, Seed
- Australia, United States, The Netherlands
Portfolio highlights
- Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Paul Davidson joined private equity group, West Coast Capital in 2005 following a successful career in corporate law in the UK, the US and Commonwealth of Independent States. As an active partner in West Coast Capital as well as providing legal counsel, Paul focusses on deal sourcing and transacting.Since joining the group, Paul has successfulyled the acquisition and delisting from the LSE of the UK's largest garden centre business, Wyevale as well as a series of acquisitions and disposals.Prior to joining West Coast Capital headed the corporate team of UK lawyers, McGrigors.In late 1994 Paul was seconded to an oil and gas company called JKX whose focus was on the former Soviet Union, primarily in Ukraine, Georgia and the Russian Federation. JKX listed on the London Stock Exchange in mid 1995 and at that time Paul joined the company as its Legal Director on a full time basis. During his time as Legal Director, Paul gained wide commercial experience as the company concluded a number of transactions throughout the former Soviet Union.
Show more
Investment focus
- SaaS, FinTech, Privacy
- Seed, Series A, Series B
- Finland, New Zealand, United Kingdom
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
- TVSquared — With trusted, independent attribution and partnerships with DSPs, publishers, advertisers and MVPDs, TVSquared measures the effectiveness of TV advertising through an infinitely scalable platform for linear, addressable and OTT/CTV.
- Ubisecure — Ubisecure B2B IAM, Legal Entity Identifiers LEI, IDaaS and hybrid identity management. European SSO, MFA, LEI made easy.
Latesha Randall is the Co- Founder at Raglan Coconut Yoghurt. Latesha attended Homeschooled.
Show more
Investment focus
- Biotechnology, Product Research
- Seed
- New Zealand
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
Serge has a depth of experience in technology startups that is difficult to rival. As CMO of M-Com, Serge led the growth of M-Com from a four person mobile commerce development company to the world's most successful provider of mobile banking and payment solutions (in both licensed and SaaS categories). He has since held executive levelpositions and Directorships, including as Chair on four boards, of many successful B2B SaaS companies. He is also an avid investor.
Show more
Investment focus
- Biotechnology, Product Research
- Seed
- New Zealand
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
Daniel Petre is the Founder of StartGiving. He was a Founding Chairman and Board Member at Ninemsn. He attended the University of Sydney.
Show more
Investment focus
- SaaS, Software, Health Care
- Seed, Series A, Series B
- Australia, Canada
Portfolio highlights
- Ento — Humanforce uses smart powered technology to transform the way you engage your workforce - unified payroll, easy onboarding, auto rostering, smart time capture and more.
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Kismet — Find the best disability or healthcare service to support your journey
Investor
Show more
Investment focus
- Biotechnology, Product Research
- Seed
- New Zealand
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
Marko retired as CEO of Morrison & Co in 2021 after 13 years of leading the business. He continues to provide guidance for investments in telecommunications and digital infrastructure. His 30 year career has been in the infrastructure and technology sectors in a variety of senior finance, operational and sales roles in the United States and NewZealand. Prior to joining Morrison & Co in 2008, Marko was CFO of Telecom NZ, responsible for corporate finance, M&A and group strategy. Marko is Chair of Vodafone New Zealand.
Show more
Investment focus
- Biotechnology, Manufacturing
- Funding Round
- New Zealand
Portfolio highlights
- Pictor — PictorDx offers a flexible multiplex proteomics platform that delivers multiple biomarker insights simultaneously and cost-effectively for multiple sample types
Catherine Lacavera is the Chief Legal Officer of ShipBob. She previously worked at Color Health as a Chief Legal Officer. Catherine Lacavera attended the University of Toronto.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Seed, Pre-Seed
- Canada, Australia
Portfolio highlights
- Skritswap — skritswap has AI technology that enables anyone to understand anything regardless of complexity.
- HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
David Ross
Show more
Investment focus
- Biopharma, Biotechnology
- Seed
- New Zealand
Portfolio highlights
- Helico — Helico is developing a proprietary computational platform for synthetic biology research using modelling tools and AI-based prediction algorithms. The long-term aim is to develop a seed bank of different drugs able to be licensed to grow medical supplies in confined greenhouses anywhere in the world.
Investors by industry
Consumer
Proptech
Impact
Climate
Gaming
Biotech
FinTech
Marketplace
Community
Health Care
Hardware
Energy
Artificial intelligence
EdTech
Sustainability
Venture Capital
Real Estate
Photography
Clean Energy
Education
B2B
Financial Services
Big Data
Payments
Finance
Organic Food
Food and Beverage
Web3
Infrastructure
Retail
Beauty
Publishing
Video Games
Music
Art
Wellness
Franchise
Mobile
Local
Digital Media
Legal
Android
eSports
Enterprise Software
Sports
Manufacturing
Email
Medical
Social Network
Social Media
Internet
Construction
Hospitality
Platforms
Biotechnology
Cannabis
Mobile Advertising
Travel
Fitness
Recruiting
Crowdfunding
Social
Medical Device
Automotive
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Google
Non Profit
Fashion
Oil and Gas
Life Science
Theatre
Film
SaaS
Renewable Energy
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Agriculture (agtech)
Machine Learning
Media (entertainment)
Facebook
Blockchain
Investors by country
Canada
Germany
United Kingdom
Ireland
South Korea
India
Australia
New Zealand
United States
Middle East
Brazil
LATAM
Qatar
Indonesia
Asia
Europe
Belarus
Chile
Belgium
Hong Kong
Finland
Ghana
Georgia
Ethiopia
Spain
Gibraltar
Faroe Islands
Denmark
Egypt
Estonia
Costa Rica
Hungary
Greece
South Africa
Barbados
Croatia
Belize
Bahrain
Czech Republic
Algeria
Ecuador
Bulgaria
Bermuda
France
Kuwait
Malta
Morocco
Nicaragua
Mali
Lithuania
Peru
Lebanon
Jersey
Norway
Myanmar
Mauritius
Liberia
Mexico
Malaysia
Liechtenstein
Philippines
Italy
Israel
Panama
Poland
Senegal
Sierra Leone
Tunisia
Togo
Serbia
Turkey
San Marino
Thailand
Uzbekistan
Taiwan
Sweden
Tanzania
Slovenia
El Salvador
Portugal
Tajikistan
Ukraine
Puerto Rico
Uganda
Venezuela
Uruguay
Zambia
Zimbabwe
Rwanda
Russian Federation
Dominican Republic
Nigeria
Iraq
Azerbaijan
Bahamas
Iceland
Namibia
United Arab Emirates
Jamaica
Honduras
Bolivia
Isle of Man
Luxembourg
Albania
Pakistan
Singapore
Armenia
Saudi Arabia
Grenada
Jordan
Bangladesh
Argentina
Romania
Sri Lanka
China
Africa
Oceania
Japan
Vietnam
Kenya
Kazakhstan
Cayman Islands
Cambodia
Guatemala
Latvia
Cyprus
Oman
Cameroon
Austria
Switzerland
Colombia
Seychelles
Marshall Islands
Angel Investors in Oceania by industry
Retail
Real Estate
Cryptocurrency
Finance
Payments
Food and Beverage
Wellness
Medical
Enterprise
Biotech
Internet
Social Network
Manufacturing
Music
Mobile
Blockchain
Legal
Construction
Software
Enterprise Software
Sports
Fitness
Financial Services
Hospitality
Automotive
Travel
Recruiting
Platforms
FinTech
Biotechnology
Consumer
Energy
Climate
Sustainability
Proptech
Marketplace
SaaS
Community
Hardware
Beauty
Fashion
Web3
Big Data
Publishing
Infrastructure
Oil and Gas
Education
Renewable Energy
Social Media
Mobile Apps
Sporting Goods
Health Care
CleanTech
Artificial intelligence
Impact
Transportation
Email
Agriculture (agtech)
Restaurants
Venture Capital
Facebook
Media (entertainment)
B2B
Machine Learning
Organic Food
EdTech
Gaming